ClearPoint Neuro (CLPT) Net Equity Issued and Repurchased (2011 - 2025)
ClearPoint Neuro (CLPT) reported Net Equity Issued and Repurchased of $3.3 million for Q2 2025, up 19294.12% on a YoY basis from N/an in Q2 2024, and up 9697.06% sequentially from -$34000.0 in Q4 2024.
ClearPoint Neuro (CLPT) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
ClearPoint Neuro (CLPT) has 5 years of Net Equity Issued and Repurchased data on file, last reported at $3.3 million in Q2 2025.
- For the quarter ending Q2 2025, Net Equity Issued and Repurchased rose 19294.12% year-over-year to $3.3 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (down 79.79% YoY), and the FY2025 full-year result was $3.3 million, down 79.79% from the prior year.
- Net Equity Issued and Repurchased improved to $3.3 million in Q2 2025, from -$34000.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $46.8 million in Q1 2021 to a low of -$34000.0 in Q4 2024.
- A 3-year average of $13.2 million and a median of $3.3 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
- Peak annual rise in Net Equity Issued and Repurchased reached 19294.12% in 2025, while the deepest fall reached 19294.12% in 2025.
- Tracing CLPT's Net Equity Issued and Repurchased over 3 years: stood at $46.8 million in 2021, then tumbled by 100.07% to -$34000.0 in 2024, then soared by 9697.06% to $3.3 million in 2025.
- Business Quant data shows CLPT's Net Equity Issued and Repurchased at $3.3 million in Q2 2025, -$34000.0 in Q4 2024, and -$17000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | ClearPoint Neuro | 434.51 Mn | 398.91 Mn | 7.76 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Dec 31, 2024 | -34,000.00 |
| Dec 31, 2024 | -34,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 16.20 Mn |
| Mar 31, 2024 | 16.20 Mn |
| Mar 31, 2021 | 46.79 Mn |
| Mar 31, 2021 | 46.79 Mn |
| Dec 31, 2019 | 1,574.00 |
| Dec 31, 2019 | 1,574.00 |
| Sep 30, 2019 | 4,351.00 |
| Sep 30, 2019 | 4,351.00 |
| Dec 31, 2011 | 1.52 Mn |
| Dec 31, 2011 | 1.52 Mn |
| Sep 30, 2011 | 1.31 Mn |
| Sep 30, 2011 | 1.31 Mn |